Tranexamic Acid in Total Joint Arthroplasty

Publication Date: October 1, 2018
Last Updated: March 14, 2022

Recommendations

Administration of intravenous (IV), topical, and oral TXA as well as combinations of individual formulations of TXA are all effective strategies when compared to placebo for reducing calculated blood loss and the need for transfusion during the perioperative episode of a primary TJA. (S)
312070

Overview

Title

Tranexamic Acid in Total Joint Arthroplasty

Authoring Organization

American Association of Hip and Knee Surgeons